3,5-Diiodothyropropionic Acid (Synonyms: DITPA) |
| رقم الكتالوجGC18696 |
3،5-ثنائي يودوثيرروبروبيونيك هو تناظرية لهرمون الغدة الدرقية ، ويحفز تعبير mRNA ثقيل السلسلة α-myosin ، ويرتبط بمستقبل هرمون الغدة الدرقية (TR) ، مع Ka لـ 2.40 و 4.06 M-1 لـ TRα1 و TRβ1 ، على التوالي
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1158-10-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
3,5-Diiodothyropropionic acid (DITPA) is an inotropic thyroid hormone analogue of L-thyroxine that binds to the thyroid hormone receptors TRα and TRβ (Kas = 2.4 and 4.06 x 107 M-1, respectively, for human recombinant receptors).1 DITPA increases mRNA expression of α-myosin heavy chain (α-MHC) in primary rat cardiomyocytes (EC50 = ~0.5 μM). Ex vivo, DITPA prevents myocardial infarction-induced loss of contractility in rabbit cardiomyocytes when administered at a dose of 3.75 mg/kg per day.2 DITPA (3.75 mg/kg per day) increases expression of VEGF, basic fibroblast growth factor (bFGF), angiopoietin-1, and angiopoietin-1 receptor (Tie-2) as well as angiogenesis in non-infarcted cardiac tissue in rats.3 It also decreases infarct size expansion, stimulates arteriolar growth, and inhibits ventricular remodeling post-myocardial infarction in rats when administered at a dose of 3.5 mg/kg per day.4
Review for 3,5-Diiodothyropropionic Acid
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
Review for 3,5-Diiodothyropropionic Acid
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *